Ohcanbohtosat - Arwin Ridder

  • Čájehuvvo 1 - 5 / 5
Aiddostahte ozu
  1. 1
    Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding study

    Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding study... Dahkki Christopher R. Chapple, Pedro Arañó, Jackie Bosch, Dirk De Ridder, A. E. J. L. Kramer, Arwin Ridder

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder

    A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder Dahkki Christopher R. Chapple, G. Amarenco, López Aramburu, Karel Everaert, J. Liehne, Malcolm G Lucas, Viktor Vik, Arwin Ridder, Robert Snijder, Osamu Yamaguchi

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study)

    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study) Dahkki Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu‐Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen, Dudley Robinson

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    A phase II dose-ranging study of mirabegron in patients with overactive bladder

    A phase II dose-ranging study of mirabegron in patients with overactive bladder Dahkki Christopher R. Chapple, Vladimír Dvořák, P. Radziszewski, Philip Van Kerrebroeck, Jean Jacques Wyndaele, Brigitte Bosman, Peter J. Boerrigter, Ted Drogendijk, Arwin Ridder, Ingrid van der Putten-Slob, Osamu Yamaguchi

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (S... Dahkki Christian Gratzke, Rob van Maanen, Christopher R. Chapple, Paul Abrams, Sender Herschorn, Dudley Robinson, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Sang Jin Yoon, С Х Аль-Шукри, Tomasz Rechberger, Elizabeth R. Mueller

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: